OpenAlex
PricingAboutJobs
Log inGet started
Work

Incretin Mimetics as Emerging Treatments for Type 2 Diabetes

HTML

Year: 2004
Type: review
Source: Annals of Pharmacotherapy
DOI: 10.1345/aph.1e245
Authors: Scott V Joy, Philip T Rodgers, Ann C Scates
Institutions: Duke Medical Center, Duke University Health System, Duke University Hospital
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: incretin mimetics, type 2 diabetes, glucagon-like peptide-1, exenatide, liraglutide, exendin-4, glycemic control, insulin secretion, glucagon inhibition, gastric emptying, satiety, beta-cell function, pancreatic progenitor cells, hypoglycemia, adverse effects
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2122675719
FWCI: 1.086
Cites: 62
Cited by: 79
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security